AI Portfolio Summary
In 2025 Q2, Camber Capital Management LP maintained a portfolio of 36 distinct positions. The most significant new addition to the portfolio was ICON PLC, which now represents 4.10% of the total fund value. Conversely, Camber Capital Management LP completely exited their position in PFIZER INC.
Total Positions
36
Quarter
2025 Q2
Top Holding
SPY (29.0%)
Top 10 Concentration
79.2%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-25 of 36
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
SPY
PUT
SPDR S&P 500 ET...
|
PUT Option | 29.00% | 29.81% |
#1
Prev: #1
|
10.0 | -1,000,000 | -66.7% |
P
S
|
500,000 | $308,925,000 | 2011 Q1 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
ZBH
ZIMMER BIOMET H...
|
Healthcare | 8.56% | 9.05% |
#2
Prev: #2
|
3.6 | -1,250,000 | -55.6% |
P
S
|
1,000,000 | $91,210,000 | 2010 Q4 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
BAX
BAXTER INTL INC
|
Healthcare | 8.10% | 6.99% |
#3
Prev: #3
|
3.4 | -2,900,000 | -50.4% |
P
S
|
2,850,000 | $86,298,000 | 2023 Q1 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
HUM
HUMANA INC
|
Healthcare | 6.89% | 6.81% |
#4
Prev: #4
|
2.9 | -425,000 | -58.6% |
P
S
|
300,000 | $73,344,000 | 2010 Q1 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
CVS
CVS HEALTH CORP
|
Healthcare | 6.80% | 5.42% |
#5
2
Prev: #7
|
2.9 | -1,200,000 | -53.3% |
P
S
|
1,050,000 | $72,429,000 | 2009 Q4 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
GMED
GLOBUS MED INC
|
Healthcare | 4.43% | 3.25% |
#6
2
Prev: #8
|
1.9 | -450,000 | -36.0% |
P
S
|
800,000 | $47,216,000 | 2023 Q1 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
ICLR
ICON PLC
|
Healthcare | 4.10% | — |
#7
Prev: #—
|
3.6 | 300,000 | no change |
NEW
|
300,000 | $43,635,000 | 2025 Q2 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
ASND
ASCENDIS PHARMA...
|
Healthcare | 4.05% | 1.94% |
#8
6
Prev: #14
|
1.7 | -100,000 | -28.6% |
P
S
|
250,000 | $43,150,000 | 2019 Q1 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
MRK
MERCK & CO INC
|
Healthcare | 3.72% | — |
#9
Prev: #—
|
3.5 | 500,000 | no change |
NEW
|
500,000 | $39,580,000 | 2013 Q4 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
GSK
CALL
GSK PLC
|
CALL Option | 3.60% | 1.38% |
#10
7
Prev: #17
|
1.4 | no change | no change |
P
S
|
1,000,000 | $38,400,000 | 2013 Q1 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
PFE
PFIZER INC
|
Healthcare | 3.41% | 2.25% |
#11
1
Prev: #12
|
1.5 | -1,000,000 | -40.0% |
P
S
|
1,500,000 | $36,360,000 | 2010 Q1 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
BMRN
BIOMARIN PHARMA...
|
Healthcare | 3.10% | 1.26% |
#12
6
Prev: #18
|
3.3 | 100,000 | 20.0% |
P
S
|
600,000 | $32,982,000 | 2020 Q3 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
UNH
UNITEDHEALTH GR...
|
Healthcare | 2.93% | — |
#13
Prev: #—
|
3.2 | 100,000 | no change |
NEW
|
100,000 | $31,197,000 | 2009 Q4 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
VTRS
VIATRIS INC
|
Healthcare | 2.31% | 2.32% |
#14
3
Prev: #11
|
1.1 | -4,750,000 | -63.3% |
P
S
|
2,750,000 | $24,557,500 | 2020 Q4 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
BKD
BROOKDALE SR LI...
|
Healthcare | 1.40% | 1.39% |
#15
1
Prev: #16
|
0.8 | -4,100,000 | -65.6% |
P
S
|
2,150,000 | $14,964,000 | 2015 Q4 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
ZIMV
ZIMVIE INC
|
Unknown | 1.40% | 0.72% |
#16
7
Prev: #23
|
0.6 | -285,000 | -15.1% |
P
S
|
1,600,000 | $14,960,000 | 2022 Q1 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
APLS
APELLIS PHARMAC...
|
Healthcare | 1.38% | — |
#17
Prev: #—
|
2.6 | 850,000 | no change |
NEW
|
850,000 | $14,713,500 | 2025 Q2 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
MYGN
MYRIAD GENETICS...
|
Healthcare | 1.00% | 0.74% |
#18
4
Prev: #22
|
0.4 | -350,000 | -14.9% |
P
S
|
2,000,000 | $10,620,000 | 2010 Q1 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
EVH
EVOLENT HEALTH ...
|
Healthcare | 0.90% | 1.01% |
#19
1
Prev: #20
|
0.6 | -2,150,000 | -71.7% |
P
S
|
850,000 | $9,571,000 | 2022 Q1 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
CON
CONCENTRA GROUP...
|
Healthcare | 0.77% | 1.23% |
#20
1
Prev: #19
|
0.5 | -1,200,000 | -75.0% |
P
S
|
400,000 | $8,228,000 | 2024 Q3 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
INGN
INOGEN INC
|
Healthcare | 0.64% | 0.25% |
#21
8
Prev: #29
|
0.3 | no change | no change |
P
S
|
975,000 | $6,854,250 | 2021 Q4 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
DNLI
DENALI THERAPEU...
|
Healthcare | 0.53% | 0.60% |
#22
3
Prev: #25
|
0.4 | -850,000 | -68.0% |
P
S
|
400,000 | $5,596,000 | 2024 Q1 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
TBPH
THERAVANCE BIOP...
|
Healthcare | 0.47% | 0.32% |
#23
4
Prev: #27
|
0.4 | -550,000 | -55.0% |
P
S
|
450,000 | $4,963,500 | 2021 Q3 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
ANAB
ANAPTYSBIO INC
|
Healthcare | 0.26% | 0.50% |
#24
2
Prev: #26
|
0.4 | -625,000 | -83.3% |
P
S
|
125,000 | $2,775,000 | 2024 Q2 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
OSUR
ORASURE TECHNOL...
|
Healthcare | 0.25% | 0.11% |
#25
6
Prev: #31
|
0.1 | no change | no change |
P
S
|
900,000 | $2,700,000 | 2015 Q1 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
PFE
CALL
PFIZER INC
|
CALL Option | 0.00% | 6.12% |
Sold All 😨
(Was: #5) |
0.3 | -6,800,000 | -100.0% |
CLOSED
|
— | $— | 2010 Q1 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
XBI
PUT
SPDR SER TR
|
PUT Option | 0.00% | 5.76% |
Sold All 😨
(Was: #6) |
0.3 | -2,000,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
PTCT
PTC THERAPEUTIC...
|
Healthcare | 0.00% | 2.72% |
Sold All 😨
(Was: #9) |
0.3 | -1,500,000 | -100.0% |
CLOSED
|
— | $— | 2014 Q3 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
CI
THE CIGNA GROUP
|
Healthcare | 0.00% | 2.34% |
Sold All 😨
(Was: #10) |
0.3 | -200,000 | -100.0% |
CLOSED
|
— | $— | 2015 Q2 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
QGEN
QIAGEN NV
|
Healthcare | 0.00% | 2.00% |
Sold All 😨
(Was: #13) |
0.3 | -1,400,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
SRPT
SAREPTA THERAPE...
|
Healthcare | 0.00% | 1.81% |
Sold All 😨
(Was: #15) |
0.3 | -800,000 | -100.0% |
CLOSED
|
— | $— | 2013 Q3 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
IONS
IONIS PHARMACEU...
|
Healthcare | 0.00% | 0.78% |
Sold All 😨
(Was: #21) |
0.3 | -725,000 | -100.0% |
CLOSED
|
— | $— | 2021 Q1 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
MLTX
MOONLAKE IMMUNO...
|
Healthcare | 0.00% | 0.61% |
Sold All 😨
(Was: #24) |
0.3 | -441,000 | -100.0% |
CLOSED
|
— | $— | 2024 Q2 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
TXG
10X GENOMICS IN...
|
Healthcare | 0.00% | 0.31% |
Sold All 😨
(Was: #28) |
0.3 | -1,000,000 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
GPCR
STRUCTURE THERA...
|
Healthcare | 0.00% | 0.18% |
Sold All 😨
(Was: #30) |
0.3 | -300,000 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) | |||
|
GMAB
GENMAB A/S
|
Healthcare | 0.00% | 0.03% |
Sold All 😨
(Was: #32) |
0.3 | -50,000 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2025-06-30 | 2025-08-14 (Est.) |
Showing 1-25 of 36 holdings